Karin Birgitta Margareta Ståhl
Geschäftsführer bei Akinion Pharmaceuticals AB
Profil
Karin Birgitta Margareta Ståhl is currently the Chief Operating Officer & Vice President at Akinion Pharmaceuticals AB and the Vice President-Company Operations at KDev Oncology AB.
Previously, she worked as the Chief Financial Officer at Oncopeptides AB from 2016 to 2018.
She also held positions as Vice President-Company Operations at Axelar AB, Principal at Ingenix Pharmaceutical Services, Inc., Principal at Novartis Sverige AB, Principal at Pfizer AB, and Chief Operating Officer at Betagenon Sweden AB.
Ms. Margareta Ståhl holds a doctorate degree from the University of Uppsala and an MBA from the University of Westminster.
Aktive Positionen von Karin Birgitta Margareta Ståhl
| Unternehmen | Position | Beginn |
|---|---|---|
Akinion Pharmaceuticals AB
 Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Geschäftsführer | - |
KDev Oncology AB
 KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services KDev Oncology AB offers research and development of new cancer treatments. It provides know-how in the field of oncology. The company was founded by David Jern on July 14, 2005 and is headquartered in Solna, Sweden. | Geschäftsführer | - |
Ehemalige bekannte Positionen von Karin Birgitta Margareta Ståhl
| Unternehmen | Position | Ende |
|---|---|---|
| ONCOPEPTIDES AB | Finanzdirektor/CFO | 01.11.2018 |
Novartis Sverige AB
 Novartis Sverige AB Pharmaceuticals: MajorHealth Technology Novartis Sverige AB trades pharmaceutical products. It offers products for the treatment of ADHD, multiple sclerosis, urticaria, allergic asthma, psoriasis, chronic obstructive pulmonary disorder, migraine, blood diseases, eye disorder, and other diseases. The company is headquartered in Kista, Sweden. | Corporate Officer/Principal | - |
Betagenon Sweden AB
 Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Betagenon AB engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases. The company was founded by Helena Edlund, Thomas Edlund and Olof Karlsson and is headquartered in Umea, Sweden. | Geschäftsführer | - |
Ingenix Pharmaceutical Services, Inc.
 Ingenix Pharmaceutical Services, Inc. Packaged SoftwareTechnology Services Part of UnitedHealth Group, Inc., Ingenix Pharmaceutical Services, Inc. provides healthcare information technology and consulting services. The company is based in Basking Ridge, NJ. | Corporate Officer/Principal | - |
| Pfizer AB | Corporate Officer/Principal | - |
Ausbildung von Karin Birgitta Margareta Ståhl
| University of Uppsala | Doctorate Degree |
| University of Westminster | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ONCOPEPTIDES AB | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Axelar AB
 Axelar AB BiotechnologyHealth Technology Axelar AB operates as a biotechnology company. It aims to develop novel efficacious anti-cancer treatments. The company was founded by Erik Gustav Magnus Axelson and Lars Olov Larsson in 2003 and is headquartered in Solna, Sweden. | Health Technology |
| Pfizer AB | |
Ingenix Pharmaceutical Services, Inc.
Ingenix Pharmaceutical Services, Inc. Packaged SoftwareTechnology Services Part of UnitedHealth Group, Inc., Ingenix Pharmaceutical Services, Inc. provides healthcare information technology and consulting services. The company is based in Basking Ridge, NJ. | Technology Services |
Betagenon Sweden AB
Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Betagenon AB engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases. The company was founded by Helena Edlund, Thomas Edlund and Olof Karlsson and is headquartered in Umea, Sweden. | Health Technology |
Akinion Pharmaceuticals AB
Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Health Technology |
Novartis Sverige AB
Novartis Sverige AB Pharmaceuticals: MajorHealth Technology Novartis Sverige AB trades pharmaceutical products. It offers products for the treatment of ADHD, multiple sclerosis, urticaria, allergic asthma, psoriasis, chronic obstructive pulmonary disorder, migraine, blood diseases, eye disorder, and other diseases. The company is headquartered in Kista, Sweden. | Health Technology |
KDev Oncology AB
KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services KDev Oncology AB offers research and development of new cancer treatments. It provides know-how in the field of oncology. The company was founded by David Jern on July 14, 2005 and is headquartered in Solna, Sweden. | Commercial Services |
